topicBerberine Triglycerides Meta-Analysis
claimThis review was based on a narrative literature search designed to identify experimental, clinical, and translational evidence linking natural products with gut barrier integrity, gut microbiota, low-grade inflammation, and metabolic endotoxemia.
evidence level3
citationŠantić Roko (2026)
sourceNatural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives
topicBerberine Triglycerides Meta-Analysis
claimBecause this article is a narrative review rather than a systematic review, formal risk-of-bias assessment and quantitative evidence synthesis were not performed.
evidence level3
citationŠantić Roko (2026)
sourceNatural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives
topicBerberine Triglycerides Meta-Analysis
claimOver the past two decades, accumulating evidence has repositioned the gastrointestinal tract from a passive absorptive organ to an immunologically active barrier whose functional state directly influences systemic inflammatory tone and metabolic homeostasis [].
evidence level3
citationŠantić Roko (2026)
sourceNatural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives
topicBerberine Triglycerides Meta-Analysis
claimReference lists of relevant reviews and primary studies were additionally screened to identify articles not captured by database searches.
evidence level3
citationŠantić Roko (2026)
sourceNatural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives
topicBerberine Triglycerides Meta-Analysis
claim1 2 3 4 5 6 7 8 9 10 The concept of metabolic syndrome was first introduced in 1988 as “Syndrome X” to describe the frequent clustering of insulin resistance with metabolic abnormalities that increase the risk of type 2 diabetes mellitus and cardiovascular disease [,].
evidence level3
citationStarvaggi Josè (2026)
sourceSelected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications
topicBerberine Triglycerides Meta-Analysis
claimThis definition identifies metabolic syndrome based on the presence of at least three of the following components: increased waist circumference (population specific), hypertriglyceridemia and/or reduced HDL cholesterol, elevated blood pressure, and impaired fasting glucose [,].
evidence level3
citationStarvaggi Josè (2026)
sourceSelected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications
topicBerberine Triglycerides Meta-Analysis
claim15 16 17 14 18 Accumulating evidence indicates that fat distribution rather than total adiposity is the principal determinant of metabolic risk.
evidence level3
citationStarvaggi Josè (2026)
sourceSelected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications
topicBerberine Triglycerides Meta-Analysis
claimThe term was later refined to “metabolic syndrome” to avoid confusion with cardiac Syndrome X and to better reflect the underlying metabolic dysregulation [].
evidence level3
citationStarvaggi Josè (2026)
sourceSelected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications